CA2464735A1 - Solution d'inhalation a base d'albuterol et d'ipratropium, et systeme, kit et methode permettant de soulager les symptomes de la bronchopneumopathie chronique obstructive - Google Patents

Solution d'inhalation a base d'albuterol et d'ipratropium, et systeme, kit et methode permettant de soulager les symptomes de la bronchopneumopathie chronique obstructive Download PDF

Info

Publication number
CA2464735A1
CA2464735A1 CA002464735A CA2464735A CA2464735A1 CA 2464735 A1 CA2464735 A1 CA 2464735A1 CA 002464735 A CA002464735 A CA 002464735A CA 2464735 A CA2464735 A CA 2464735A CA 2464735 A1 CA2464735 A1 CA 2464735A1
Authority
CA
Canada
Prior art keywords
solution
albuterol
inhalation solution
containers
nebulizer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002464735A
Other languages
English (en)
Other versions
CA2464735C (fr
Inventor
Imtiaz Chaudry
Partha Banerjee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mylan Specialty LP
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2002158304A external-priority patent/JP2003221335A/ja
Application filed by Individual filed Critical Individual
Publication of CA2464735A1 publication Critical patent/CA2464735A1/fr
Application granted granted Critical
Publication of CA2464735C publication Critical patent/CA2464735C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Solution d'inhalation à base de deux bronchodilatateurs, et système, kit et méthode permettant de soulager le bronchospasme chez les patients souffrant de bronchopneumopathie chronique obstructive. Dans un mode de réalisation, la solution selon la présente invention est une dose unitaire préemballée, stérile, prémélangée et prémesurée d'albutérol et de bromure d'ipratropium pour des patients souffrant de bronchopneumopathie chronique obstructive. Cette solution peut être exempte de produits chimiques anti-microbiens tels que le chlorure de benzalconium. Dans un autre mode de réalisation, la solution selon la présente invention contient environ 2,50 mg d'albutérol et environ 0,50 mg de bromure d'ipratropium.
CA2464735A 2001-10-26 2002-10-18 Solution d'inhalation a base d'albuterol et d'ipratropium, et systeme, kit et methode permettant de soulager les symptomes de la bronchopneumopathie chronique obstructive Expired - Fee Related CA2464735C (fr)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US34607801P 2001-10-26 2001-10-26
US60/346,078 2001-10-26
US10/034,657 2001-12-27
US3465701A 2001-12-28 2001-12-28
AU32974/02 2002-04-05
AU32974/02A AU3297402A (en) 2001-10-26 2002-04-05 An albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
JP2002158304A JP2003221335A (ja) 2001-10-26 2002-04-23 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法
JP2002-158304 2002-04-23
PCT/US2002/033353 WO2003037159A2 (fr) 2001-10-26 2002-10-18 Solution d'inhalation a base d'albuterol et d'ipratropium, et systeme, kit et methode permettant de soulager les symptomes de la bronchopneumopathie chronique obstructive

Publications (2)

Publication Number Publication Date
CA2464735A1 true CA2464735A1 (fr) 2003-05-08
CA2464735C CA2464735C (fr) 2011-03-22

Family

ID=27422968

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2464735A Expired - Fee Related CA2464735C (fr) 2001-10-26 2002-10-18 Solution d'inhalation a base d'albuterol et d'ipratropium, et systeme, kit et methode permettant de soulager les symptomes de la bronchopneumopathie chronique obstructive

Country Status (8)

Country Link
EP (1) EP1446045A4 (fr)
JP (1) JP2006505486A (fr)
CN (2) CN1939279A (fr)
AU (1) AU3297402A (fr)
CA (1) CA2464735C (fr)
MX (1) MXPA04003927A (fr)
NZ (1) NZ552548A (fr)
WO (1) WO2003037159A2 (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1915985A1 (fr) * 2003-03-20 2008-04-30 Boehringer Ingelheim Pharmaceuticals Inc. Formulation pour une dose mesurée utilisant des hydro-fluoro-alcanes en tant que propulseurs
GB0501956D0 (en) * 2005-01-31 2005-03-09 Arrow Internat Nebulizer formulation
WO2007137206A2 (fr) * 2006-05-18 2007-11-29 Tika Läkemedel Ab Préparations de doses unitaires comprenant une solution inhalable d'albutérol
US20100056559A1 (en) 2006-05-19 2010-03-04 Boehringer Ingelheim International Gmbh Propellant-free aerosol formulation for inhalation
WO2007134965A1 (fr) * 2006-05-19 2007-11-29 Boehringer Ingelheim International Gmbh Formulation d'aérosol contenant du bromure d'ipratropium et du sulfate de salbutamol
EP2077132A1 (fr) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispositif distributeur, dispositif de stockage et procédé pour la distribution d'une formulation
EP2414560B1 (fr) 2009-03-31 2013-10-23 Boehringer Ingelheim International GmbH Procédé de revêtement d'une surface d'un composant
WO2010133294A2 (fr) 2009-05-18 2010-11-25 Boehringer Ingelheim International Gmbh Adapteur, dispositif d'inhalation et nébuliseur
MX2012005961A (es) 2009-11-25 2012-06-14 Boehringer Ingelheim Int Nebulizador.
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
WO2011064163A1 (fr) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nébuliseur
JP5874724B2 (ja) 2010-06-24 2016-03-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
EP2670242B1 (fr) * 2011-01-31 2022-03-16 Avalyn Pharma Inc. Composés analogues de pyridone et de pirfénidone en aérosol, et leurs utilisations
EP2694220B1 (fr) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Appareil médical pourvu d'un récipient
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (fr) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Pulvérisateur comprenant des moyens de détrompage
EP3030298B1 (fr) 2013-08-09 2017-10-11 Boehringer Ingelheim International GmbH Nébuliseur
EP2835146B1 (fr) 2013-08-09 2020-09-30 Boehringer Ingelheim International GmbH Atomiseur
JP2016539126A (ja) * 2013-11-22 2016-12-15 テバ ブランデッド ファーマシューティカル プロダクツ アール アンド ディー インコーポレイテッド 吸引可能薬剤
CA2930170A1 (fr) 2013-11-22 2015-05-28 Teva Branded Pharmaceutical Products R&D, Inc. Medicament inhalable
DK3139982T3 (da) 2014-05-07 2022-05-16 Boehringer Ingelheim Int Forstøver
PL3139979T3 (pl) 2014-05-07 2023-12-27 Boehringer Ingelheim International Gmbh Jednostka, nebulizator i sposób
EP3139984B1 (fr) 2014-05-07 2021-04-28 Boehringer Ingelheim International GmbH Nébuliseur
CN106344544A (zh) * 2016-08-25 2017-01-25 杭州百诚医药科技股份有限公司 一种用于治疗支气管哮喘的雾化吸入制剂
CN110898042B (zh) * 2019-12-12 2020-10-16 深圳大佛药业股份有限公司 一种吸入用硫酸沙丁胺醇溶液剂及其制备方法
CN111053761B (zh) * 2020-01-16 2022-05-03 杭州旦承医药科技有限公司 一种吸入用双膦酸类药物及其制备方法及其在慢性阻塞性肺疾病的用途
WO2021188809A1 (fr) * 2020-03-19 2021-09-23 Cai Gu Huang Formulation inhalable d'une solution contenant du tartrate de lévalbutérol
CN113018280A (zh) * 2021-03-01 2021-06-25 石家庄四药有限公司 一种异丙托溴铵吸入用溶液制剂及其制备方法
CN115645381B (zh) * 2022-10-20 2023-05-30 深圳大佛药业股份有限公司 一种盐酸左沙丁胺醇雾化吸入溶液缓释剂及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994013262A1 (fr) * 1992-12-09 1994-06-23 Boehringer Ingelheim Pharmaceuticals, Inc. Formulations de solutions medicinales aerosol stabilisees
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
US6247617B1 (en) * 1999-12-13 2001-06-19 Richard Allen Clyde Single use container for dispensing separately housed sterile compositions

Also Published As

Publication number Publication date
WO2003037159A3 (fr) 2003-10-16
CN1607940A (zh) 2005-04-20
CN1939279A (zh) 2007-04-04
MXPA04003927A (es) 2005-03-31
JP2006505486A (ja) 2006-02-16
WO2003037159A2 (fr) 2003-05-08
NZ552548A (en) 2009-03-31
CA2464735C (fr) 2011-03-22
EP1446045A4 (fr) 2010-07-21
EP1446045A2 (fr) 2004-08-18
AU3297402A (en) 2003-10-30

Similar Documents

Publication Publication Date Title
CA2464735A1 (fr) Solution d'inhalation a base d'albuterol et d'ipratropium, et systeme, kit et methode permettant de soulager les symptomes de la bronchopneumopathie chronique obstructive
US6702997B2 (en) Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
US6632842B2 (en) Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
AU2002347948A1 (en) Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
TW300886B (fr)
US20030191151A1 (en) Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
JP2009544715A (ja) 抗片頭痛の口腔噴霧製剤及び方法
RU2173559C2 (ru) Назальное введение десмопрессина
CA2768006A1 (fr) Schema posologique pour l'administration d'olopatadine en pulverisation nasale a des enfants
JP2916340B2 (ja) ナトリウムクロモグリケートの水性医薬組成物
CA2541849A1 (fr) Preparation liquide contenant de la tobramycine
JP2008528565A (ja) ネブライザー処方物
WO2004091536A2 (fr) Solution d'inhalation d'albuterol et d'ipratropium inhalation, kit et procede de soulagement de symptomes de maladie pulmonaire obstructive chronique
GB2224932A (en) Pharmaceutical solution containing cromogycic acid and salbutamol
US20030140920A1 (en) Albuterol inhalation soultion, system, kit and method for relieving symptoms of pediatric asthma
AU2006202585B2 (en) An albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
AU2002353825B2 (en) An albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
IE64476B1 (en) Pharmaceutical compositions
US20050175544A1 (en) Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
US8084461B2 (en) Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
AU2002353825A1 (en) An albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
CA2464660A1 (fr) Solution d'inhalation a base d'albuterol, et systeme, kit et methode permettant de soulager les symptomes de l'asthme pediatrique
AU2006202584B2 (en) An albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
JP2010184937A (ja) 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、キット、吸入溶液を中に有する１容器を作成する方法、および、吸入溶液を作成する方法

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20201019